Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis. 2022

Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.

High level of apolipoprotein B (Apo B) is associated with incident subclinical atherosclerosis. The present study evaluated the associations between discordant Apo B with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and coronary atherosclerotic burden. This study enrolled 3043 participants aged 50-75 years from the PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE) study that was conducted in the community in Lishui City, China. Discordant Apo B with LDL-C and non-HDL-C were defined by residuals and medians. Coronary atherosclerotic burden was evaluated by segment involvement score (SIS) and segment stenosis score (SSS) which were determined by computed tomography angiography. We performed discordance analyses examining associations of discordant Apo B with LDL-C or non-HDL-C with the coronary atherosclerotic burden. The mean age of participants was 61.2 ± 6.7 years, 53.6% were females. Participants with discordant high Apo B relative to non-HDL-C were at higher odds of plaques [odds ratio (OR), 1.30; 95% confidence interval (CI), 1.08-1.57], SIS [common odds ratio (cOR), 1.35; 95% CI, 1.14-1.60], and SSS (cOR, 1.40; 95% CI, 1.18-1.67) compared with concordant group. However, discordantly low Apo B with non-HDL-C was associated with decreased odds of the coronary atherosclerotic plaques and its burden. Similar results were shown for discordant analyses for Apo B with LDL-C. Discordantly high Apo B with LDL-C and non-HDL-C were associated with an increased odds of the coronary atherosclerotic plaques and its burden. These findings highlighted the importance of Apo B for primary prevention of coronary atherosclerosis.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B

Related Publications

Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
January 2020, Journal of clinical lipidology,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
January 2020, Arquivos brasileiros de cardiologia,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
January 2011, Journal of clinical lipidology,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
October 2016, Journal of the American Heart Association,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
January 2024, Current opinion in cardiology,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
November 2023, International journal of cardiology,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
November 2005, The American journal of cardiology,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
January 2004, Scandinavian journal of clinical and laboratory investigation,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
December 2012, Journal of the American College of Cardiology,
Xin Su, and Xueli Cai, and Yuesong Pan, and Jingping Sun, and Jing Jing, and Mengxing Wang, and Xia Meng, and Yongjun Wang, and Tiemin Wei, and Yan He
August 2023, Lipids in health and disease,
Copied contents to your clipboard!